Combined Treatment of Cisplatin With Caffeic Acid Phenethyl Ester Demonstrates Additive Growth Inhibition on Non-small Cell Lung Cancer Cells
Combined treatment of cisplatin with CAPE may reduce the required dose of cisplatin for growth inhibition of NSCLC cells and delay or prevent the development of drug resistance in NSCLC.
Authors
- L. Shih (ORCID: https://orcid.org/0000-0002-2933-3306)
- Chih‐Jen Lai (ORCID: https://orcid.org/0000-0002-0355-7846)
- Shu‐Pin Huang (ORCID: https://orcid.org/0000-0003-2968-6125)
- Shih-Wei Lee (ORCID: https://orcid.org/0000-0001-5146-011X)
- Li‐Jen Kuo (ORCID: https://orcid.org/0000-0002-4865-325X)
- Yongsheng Huang (ORCID: https://orcid.org/0000-0002-8449-7522)
- Chih‐Pin Chuu (ORCID: https://orcid.org/0000-0001-7206-7923)
- Yuting Fu (ORCID: https://orcid.org/0009-0007-7585-1239)
- Ching-Yi Lee (ORCID: https://orcid.org/0000-0002-9662-0428)
- C Li
- Chiech Huo
- C.‐T. Yeh
- Ying‐Yu Kuo
Institutions
- Kaohsiung Medical University (TW)
- National Chung Hsing University (TW)
- National Health Research Institutes (TW)
- Yuanpei University (TW)
- Mackay Medical University (TW)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-10-28
- DOI
- https://doi.org/10.21873/anticanres.17840
- Primary Topic
- Bee Products Chemical Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00